ETHYL PYRAZOLO[1,5-A]PYRIMIDINE-2-CARBOXYLATE, 95.0%, 250mg

1,3-dimethylurea, 98.0%, 100g

4-Methylnonanoic acid, 95.0%, 100g

2-Chloro-8-methoxyquinoxaline, 95.0%, 250mg

(S)-2-Amino-3-(pyridin-4-yl)propanoic acid, 95.0%, 1g

3,4-Diméthoxybenzaldéhyde, min 99 %, pour la synthèse, 100 g, emballage plastique.

(3-Methylpyridin-4-yl)boronic acid hydrochloride, 95.0%, 250mg

2-Benzothiazolecarboxamide, 95.0%, 1g

(3R)-(+)-1-(tert-Butoxycarbonyl)-3-aminopyrrolidine>98.0%(GC)(T)1g

8-Hydroxy-[1,7]naphthyridine-5-carboxylic acid, 95.0%, 100mg

5-Fluoro-1H-pyrrolo[2,3-b]pyridine, 95.0%, 1g

6-(chloromethyl)-1-methyl-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, 95.0%, 5g

ETHYL 6-BROMO-1H-INDOLE-3-CARBOXYLATE, 95.0%, 5g